{"id":141337,"date":"2024-12-24T11:58:06","date_gmt":"2024-12-24T06:28:06","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=141337"},"modified":"2024-12-24T11:58:09","modified_gmt":"2024-12-24T06:28:09","slug":"pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/","title":{"rendered":"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-503588454\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3547664213\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price Action&nbsp;<\/strong><\/h2><p>With a market capitalization of 310.48 Crores on Tuesday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/543616\" target=\"_blank\" rel=\"noreferrer noopener\">Trident Lifeline Ltd<\/a><\/strong> fell by 1.82 percent marking a day\u2019s low of Rs 270 compared to its previous closing price of Rs 410.70. The stock has delivered around 42 percent in the past year and has outperformed the Nifty Index.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened&nbsp;<\/strong><\/h2><p>The stocks of Trident Lifeline rose after the company\u2019s board to acquire 51 percent of Trident Mediquip. This acquisition would allow the company to aid in improving its presence. The time period for this acquisition is approximately one month. In FY24, the Trident Mediquip has Rs. 20.58 crore as turnover and it is in the business of pharmaceutical and chemical business.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Trident Lifeline Limited was established in 2014. It is a pharmaceutical company focused on providing high-quality and affordable medications. Their business model includes manufacturing finished dosages under its own brands, utilizing a loan license model, and engaging in contract manufacturing.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1283405963\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>They operate primarily in emerging markets across Africa and Asia, with a strong global supply chain and a commitment to improving access to essential pharmaceuticals. Trident Lifeline aims to expand its product portfolio over the period.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials &amp; Ratios&nbsp;<\/strong><\/h2><p>Its Revenue from operations increased by 57.42 percent year on year from Rs. 18.58 Crore in H1FY24 to Rs. 29.25 Crore in Q2FY25, accompanied by profits of Rs. 3.11 Crore to Rs. 4.41 Crore.&nbsp;<\/p><p>In terms of Return ratios, it has reported a return on equity (ROE) of 12.06 percent and a return on capital employed (ROCE) of 14.99 percent. It has a net profit margin of 13.31 percent as of FY24.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Shareholding Pattern&nbsp;<\/strong><\/h2><p>As of September 2024, the shareholding pattern with the promoter&#8217;s stake holding a share of 62.99 percent in Trident Lifeline, Foreign Institutional investors (FII) holding around 6.09 percent, and public holdings standing at 30.92 percent.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Santhosh S&nbsp;<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-699207125\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-2123433053\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.&nbsp; Price Action&nbsp; With a market capitalization of 310.48 Crores on Tuesday, the shares of Trident Lifeline Ltd fell by 1.82 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[6616,948,936,2597,25743,25744,25746],"class_list":["post-141337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch","tag-trident-lifelin","tag-trident-lifelin-share-price","tag-trident-lifelin-trending-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0\" \/>\n<meta property=\"og:description\" content=\"This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-24T06:28:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-24T06:28:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/\",\"name\":\"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-12-24T06:28:06+00:00\",\"dateModified\":\"2024-12-24T06:28:09+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0 - Trade Brains Features","description":"This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0","og_description":"This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-24T06:28:06+00:00","article_modified_time":"2024-12-24T06:28:09+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/","name":"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-12-24T06:28:06+00:00","dateModified":"2024-12-24T06:28:09+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"This Microcap Pharma stock which deals in the business of pharma formulations under its own brands, loan license, and contract manufacturing model is in focus after the acquisition of 51% stake approval of Trident Mediquip.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-in-focus-after-acquiring-51-stake-in-trident-mediquip\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock in focus after acquiring 51% stake in Trident Mediquip\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=141337"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141337\/revisions"}],"predecessor-version":[{"id":141340,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141337\/revisions\/141340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=141337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=141337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=141337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}